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Arrhythmogenic cardiomyopathy has been clinically defined since the 1980s and causes
right or biventricular cardiomyopathy associated with ventricular arrhythmia. Although
it is a rare cardiac disease, it is responsible for a significant proportion of sudden
cardiac deaths, especially in athletes. The majority of patients with arrhythmogenic
cardiomyopathy carry one or more genetic variants in desmosomal genes. In the 1990s,
several knockout mouse models of genes encoding for desmosomal proteins involved
in cell–cell adhesion revealed for the first time embryonic lethality due to cardiac defects.
Influenced by these initial discoveries in mice, arrhythmogenic cardiomyopathy received
an increasing interest in human cardiovascular genetics, leading to the discovery
of mutations initially in desmosomal genes and later on in more than 25 different
genes. Of note, even in the clinic, routine genetic diagnostics are important for risk
prediction of patients and their relatives with arrhythmogenic cardiomyopathy. Based on
improvements in genetic animal engineering, different transgenic, knock-in, or cardiac-
specific knockout animal models for desmosomal and nondesmosomal proteins have
been generated, leading to important discoveries in this field. Here, we present an
overview about the existing animal models of arrhythmogenic cardiomyopathy with a
focus on the underlying pathomechanism and its importance for understanding of this
disease. Prospectively, novel mechanistic insights gained from the whole animal, organ,
tissue, cellular, and molecular levels will lead to the development of efficient personalized
therapies for treatment of arrhythmogenic cardiomyopathy.
Keywords: arrhythmogenic cardiomyopathy, desmosomes, animal models of human disease, sudden death,
genetics, mouse, zebrafish
INTRODUCTION
Arrhythmogenic cardiomyopathy (ACM) is a genetic cardiomyopathy characterized by ventricular
arrhythmia often leading to sudden cardiac death in young people. Ventricular dysfunction often
develops with progression of the disease leading to heart failure in some cases (Sen-Chowdhry and
McKenna, 2010). ACM is frequently associated with fibro-fatty replacement of the myocardium
(Slesnick et al., 2019). For a long time, the disease was referred to as arrhythmogenic right
ventricular cardiomyopathy (ARVC) because the phenotype description was more focused on
features of the right ventricle; however, increasing awareness of left ventricular and biventricular
involvement led to the term “ACM” (Sen-Chowdhry et al., 2010). Because of the broad spectrum
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of ACM-related phenotypes sometimes overlapping with other
cardiomyopathies, we follow in this review the recommendations
of the Heart Rhythm Society (HRS) and focus on the genetic
etiology of this disease (Protonotarios and Elliott, 2019; Towbin
et al., 2019). The estimated prevalence of ACM is 1 in between
1000 and 5000 (Basso et al., 2009).
Discovery of genetic causes of ACM started with two recessive
cardio-cutaneous syndromes named Naxos disease and Carvajal
syndrome (McKoy et al., 2000; Norgett et al., 2000), which guided
the discovery of autosomal dominant inherited nonsyndromic
cardiomyopathy in the direction of disturbed cell–cell adhesion,
in particular desmosomes (Figure 1). Pathogenic mutations
in genes encoding desmosomal proteins account for about
50% of the genetic etiology (Klauke et al., 2010; Gandjbakhch
et al., 2013). However, genetic mutations in additional genes
expressed in different subcellular systems have been discovered
by various genetic approaches, indicating extensive genetic
heterogeneity (Figure 1).
Moreover, genetic findings brought up that the same gene, and
sometimes even the same genetic variant, can be causative for a
wide range of clinical features, indicating that disease entities are
indistinct or clinically overlapping. For ACM, the clinical overlap
occurs in particular with dilated cardiomyopathy (DCM) with
which, sometimes, ventricular arrhythmia are the predominant
phenotype and also with primary arrhythmia syndromes such
as Brugada syndrome, in which a potential structural phenotype
may not be overt at the time of presentation (Cerrone et al.,
2014; Zegkos et al., 2020). In addition, it became more and
more evident that not only the primary genetic cause, but also
many other factors, such as environment, comorbidities, age,
genetic background, and epigenetic factors, are contributing
to disease onset, progression, and prognosis in patients with
ACM (Bondue et al., 2018). Therefore, animal models provide a
defined genetic background and are suitable to study the cause
of disease as well as confounding variables under controlled and
standardized conditions.
On the other hand, animal models also have several
limitations when applied to mimic human cardiac disease, in
particular the commonly used mouse and zebrafish models.
For example, neither mice nor zebrafish develop cardiac fatty
tissue, which is a hallmark for human ACM. Mice seem to be
less prone to genetic defects affecting the heart, which often
requires homozygous (recessive) models for mutations appearing
heterozygous (dominant) in humans. Even more limited is the
two-chamber heart of the zebrafish, which regenerates and may
not be an ideal system to mimic specific aspects (e.g., right
ventricular involvement) of ACM but has some advantages
to study electrophysiology (Vornanen and Hassinen, 2016).
Despite those limitations, animal models have contributed to
a better understanding of the pathophysiology and molecular
pathways leading to cardiomyopathy and the susceptibility to
arrhythmia. Initially, often the animal model was used to analyze
the pathological effect of a gene with consequences for the
whole organism, the organ, and at the cellular and molecular
levels. The discovery of cardiac phenotypes in animal models
followed by a forward genetic approach led to identification
of the genetic defect in the underlying human disease (Gerull
et al., 2004; Grossmann et al., 2004). With the advances in
genetic technology, often the disease gene in humans was first
identified and subsequently modeled according to the mutation
and proposed genetic mechanism (Heuser et al., 2006; Brodehl
et al., 2019d). In this review, we evaluate the current state of
animal models for ACM according to the proposed human
disease–associated genes (Figure 1) and briefly discuss relevant
mechanistic insights and limitations obtained from these studies.
Some genes are more established than others or display a broad
spectrum of phenotypes as part of an overlap syndrome. In
particular, in the latter, we focus on models of mutations that
have been associated with the ACM phenotype or representing
a general mechanistic concept.
ANIMAL MODELS FOR ACM
ASSOCIATED WITH MUTATIONS IN
DESMOSOMAL GENES
Desmosomes are multiple protein complexes mediating cell–
cell adhesion (Patel and Green, 2014). Especially in tissue
exposed to mechanical forces, such as the skin and the
heart during contraction, they have an important function
for structural integrity. In addition, desmosomes are indirectly
involved in the electrochemical coupling of cardiomyocytes
(Cerrone and Delmar, 2014) and in signal transduction (Zhao
et al., 2019). The molecular composition between cardiac
and dermal desmosomes differs significantly (Goossens et al.,
2007). For example, in the skin, all three plakophilins 1–
3 are expressed, whereas cardiomyocytes express exclusively
plakophilin-21. Proteins from three different families build the
desmosomes. In myocardial tissue, two desmosomal cadherins,
desmocollin-2 and desmoglein-2 (encoded by DSC2 and DSG2),
mediate the intercellular, Ca2+-dependent adhesion (Harrison
et al., 2016; Figure 2). The Ca2+ ion binding sites are localized
in linker regions between the extracellular cadherin domains
and are formed by aspartate and glutamate residues (Harrison
et al., 2016). Both cadherins are type-I transmembrane proteins
and carry several N-glycosylations and O-mannosylations in
their extracellular domains (Harrison et al., 2016; Brodehl et al.,
2019e; Debus et al., 2019). Their extracellular parts consist
of five extracellular cadherin domains (ECD), mainly formed
by β-sheets. Their first ECDs mediate this protein–protein
interaction in trans position. Homophilic interactions between
the desmosomal cadherins have relative high dissociation
constants (KD > 400 µM), whereas heterophilic interactions have
higher affinities (KD < 40 µM) (Harrison et al., 2016; Dieding
et al., 2017). The intracellular domains of the desmosomal
cadherins are bound in the heart by two proteins from the
Armadillo family, which are called plakoglobin and plakophilin-2
(encoded by JUP and PKP2) (Chen et al., 2002; Figure 2). Central
Armadillo domains consisting of several Armadillo repeats
formed by a hairpin of two α-helices are the typical structural
feature of these proteins (Choi et al., 2009; Kirchner et al.,
2012). Plakoglobin and plakophilin-2 mediate the molecular
1https://www.proteinatlas.org/
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FIGURE 1 | Genes associated with arrhythmogenic cardiomyopathy according to the year of discovery. Colors indicate the subcellular location and/or functional
association. Eclipses indicate genes listed by the Online Mendelian Inheritance in the Man (OMIM) database. Squares indicate further genes associated with
arrhythmogenic cardiomyopathy. JUP = plakoglobin, DSP = desmoplakin, RYR2 = ryanodine receptor-2, PKP2 = plakophilin-2, TGFβ3 = transforming growth factor
β3, DSC2 = desmocollin-2, DSG2 = desmoglein-2, TMEM43 = transmembrane protein member-43, SCN5A = sodium voltage-gated channel subunit 5α,
DES = desmin, TTN = titin, PLN = phospholamban, LMNA = lamin A/C, CTNNA3 = αT-catenin, PPP1R13L = protein phosphatase 1 regulatory subunit 13 like,
LDB3 = LIM domain binding 3, CDH2 = N-cadherin, RBM20 = RNA binding motif protein 20, TJP1 = tight junction protein-1, TP63 = tumor protein-63,
LEMD2 = LEM-domain containing protein-2, SORBS2 = sorbin and SH3 domain containing protein-2, ILK = integrin linked kinase, FLNC = filamin-C,
ACTN2 = actinin α2, SORBS2 = sorbin, and SH3 = domain containing protein-2.
interactions with the cytolinker protein desmoplakin (encoded
by DSP) (Hofmann et al., 2000). Desmoplakin forms dimers and
links the desmosomes to the intermediate filaments (IF), which
consist in the heart mainly of the muscle-specific IF-protein
desmin (encoded by DES) (Lapouge et al., 2006; Hatzfeld et al.,
2017; Figure 2).
In the 1990s, the relevance of desmosomal genes for ACM
was recognized by the attempt to generate global knockout
mice. Independently, the groups of Kemler and Birchmeier
demonstrated that global Jup deficiency causes embryonic
lethality in mice due to severe cardiac defects (Bierkamp et al.,
1996; Ruiz et al., 1996; Figure 3 and Supplementary Tables 1, 2).
The number of cardiac desmosomes was significantly reduced in
the Jup-deficient embryos. Correspondingly, it was also shown
that the global knockout ofDsp,Dsg2, and Pkp2 causes embryonic
lethality in mice due to severe heart defects (Gallicano et al.,
1998; Eshkind et al., 2002; Grossmann et al., 2004). Of note, these
initial findings stimulated the human cardiovascular genetic field
significantly. In consequence, genetic analyses of human-related
ACM patients revealed pathogenic mutations in the desmosomal
genes JUP (McKoy et al., 2000), DSP (Norgett et al., 2000),
PKP2 (Gerull et al., 2004), DSG2 (Awad et al., 2006; Pilichou
et al., 2006), and DSC2 (Heuser et al., 2006; Syrris et al., 2006;
Figure 1). Patients carrying a homozygous 2-bp JUP deletion
presented, in addition to ACM, also wooly hair and palmoplantar
keratoderma. Because these patients were from the Greek island
Naxos, this clinical triad is also known as Naxos disease (MIM,
#601214) (Protonotarios and Tsatsopoulou, 2006). Patients with
pathogenic mutations in the DSP gene frequently presented with
a comparable triad of clinical features consisting of DCM, wooly
hair, and palmoplantar keratoderma, which is known as Carvajal
syndrome (MIM, #605676) (Protonotarios and Tsatsopoulou,
2004). An additional skeletal muscle myopathy can contribute
to the phenotype of patients with mutations in DES or FLNC
(Klauke et al., 2010; Verdonschot et al., 2020).
In conclusion, initial findings in mice and humans led
to the hypothesis that ACM is mainly a disease of cardiac
desmosomes supported by the fact that about 50% of ACM
patients carry one or multiple mutations in desmosomal
genes (Xu et al., 2010). Despite the stimulating effects for
human cardiovascular genetics, embryonic lethality associated
with global desmosomal gene deficiency limited the molecular
analyses of the underlying pathomechanisms involved in ACM.
Cellular models, including cardiomyocytes derived from human-
induced pluripotent stem cells (hiPSC), might be an alternative
approach for in vitro analyses (for a review about hiPSC
ACM models, see Brodehl et al. (2019a). In addition, different
transgenic, knock-in (KI), and conditional cardiac-specific
mouse models for the desmosomal genes have been developed
to overcome embryonic lethality (Figure 3 and Supplementary
Tables 1, 2). Different animal studies revealed that the number of
cardiac desmosomes is decreased. In addition, the ultrastructure
of the cardiac desmosomes is also significantly changed (Heuser
et al., 2006). Both effects might contribute to a widening of
the intercalated disc. In consequence, the electrical coupling
of adhesive cardiomyocytes through gap junctions might be
indirectly affected, which can explain an increased risk for
ventricular arrhythmia in ACM patients. This hypothesis is
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FIGURE 2 | Schematic overview of cardiac desmosomes. DSC2 =
desmocollin-2, DSG2 = desmoglein-2, PKP2 = plakophilin-2,
PG = plakoglobin, DSP = desmoplakin.
in good agreement with studies demonstrating a remarkable
mislocalization of connexin-43 at the intercalated disc, which is
the main cardiac gap junction protein (Gomes et al., 2012). More
recently, molecular and functional crosstalk between plakophilin-
2 and the voltage-gated sodium channel complex was discovered,
indicating that the sodium channel current is decreased (Agullo-
Pascual et al., 2013, 2014; Cerrone and Delmar, 2014).
In summary, the electrophysiological pathomechanisms
caused by defects in desmosomal proteins are complex and
still a matter of debate. Presumably, genetic, biochemical and
electrophysiological changes contribute in combination to the
complex disease phenotype of ACM.
Plakoglobin
In general, there is still an ongoing debate about if a loss-of-
function (LOF) pathomechanism or a toxic effect of mutant
plakoglobin is involved in ACM. More than 50 different rare
human JUP variants are currently listed in the Human Gene
Mutation Database (HGMD2) (Krawczak et al., 2000). For
several of the known JUP missense variants, the significance
is unknown, or they are even classified as (likely) benign.
However, homozygous truncating mutations in JUP are almost
certainly pathogenic (McKoy et al., 2000). To overcome the
embryonic lethality of global Jup deficiency in mice, additional
mice and zebrafish models have been generated (Figure 3
and Supplementary Tables 1, 2). Kirchhof and colleagues
demonstrated that even heterozygous global Jup knockout mice
developed right ventricular dilation, ventricular arrhythmia,
and decreased right ventricular function without developing
structural defects (Kirchhof et al., 2006; Fabritz et al., 2011).
Interestingly, exercise strengthened and accelerated cardiac
disease manifestation. For endurance training, the authors used
a swimming approach over 8 weeks with an increasing time
period (5–90 min) and observed an increased right ventricular
dilation and dysfunction after 6 months (Kirchhof et al., 2006).
In good agreement, knockdown via injection of morpholino
oligonucleotides induced a cardiac phenotype consisting of
cardiac edema, decreased heart size, and blood reflux between the
two cardiac chambers in zebrafish (Danio rerio) (Martin et al.,
2009). In addition, cardiac-specific or inducible cardiac-specific
plakoglobin-deficient mice developed severe cardiac fibrosis in
combination with cardiac dysfunction, ventricular arrhythmia,
and dilation (Li et al., 2011; Li et al., 2011). These findings support
an LOF pathomechanism for JUP mutations involved in ACM. In
contrast, transgenic mice with a cardiac-specific overexpression
of mutant or even wild-type plakoglobin under the control of the
cardiac-specific Myh6 promotor caused an increased mortality
in mice (Lombardi et al., 2011). Likewise, transgenic zebrafish
with an overexpression of mutant plakoglobin developed a
comparable phenotype (Asimaki et al., 2014). In 2015, the Chen’s
group generated two remarkably different KI Jup mice, carrying
a 2-bp deletion in exon 11 leading to a frame shift (Jup-c.2037-
2038del) (Zhang et al., 2015). Regular knock-in mice died shortly
after birth and showed decreased myocardial expression of
mutant plakoglobin in comparison to the wild-type control mice,
indicating that nonsense-mediated mRNA-decay (NMD) might
be involved. Exon–exon junction complexes are involved in
NMD (Dyle et al., 2020). In the second KI mice, carrying exactly
the same 2-bp deletion in Jup, the introns 10–14 were deleted
to block genetically NMD. Of note, this procedure rescued the
expression of mutant and truncated plakoglobin and prevented
the development of an ACM phenotype in these mice, supporting
a clear LOF pathomechanism (Zhang et al., 2015). In conclusion,
different animal models demonstrate that a balanced homeostasis
of plakoglobin is necessary for normal cardiac function. There
are several arguments that properties of pathogenic mutations in
JUP might be caused by LOF. However, it cannot be completely
excluded that JUP mutations have, in addition, toxic effects.
Desmoplakin
According to the HGMD, currently, nearly 200 different human
cardiomyopathy-causing DSP mutations are known. In 5%–10%
of all ACM patients, a pathogenic DSP mutation can be identified
2https://portal.biobase-international.com/hgmd/
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FIGURE 3 | Schematic overview of animal models for desmosomal genes according to the year of publication. AAV = adeno associated virus; bp = base pair,
cKO = cardiac specific knockout; ciKO = cardiac specific, inducible knockout; cidKO = cardiac specific, inducible double knockout; gKO = global knockout;
het = heterozygous; hom = homozygous; KD = knockdown; KI = knock-in. [1] (Ruiz et al., 1996); [2] (Bierkamp et al., 1996); [3] (Gallicano et al., 1998); [4] (Eshkind
et al., 2002); [5] (Grossmann et al., 2004); [6] (Garcia-Gras et al., 2006; Cheedipudi et al., 2019); [7] (Yang et al., 2006); [8] (Kirchhof et al., 2006; Fabritz et al., 2011);
[9] (Heuser et al., 2006); [10] (Pilichou et al., 2009; Rizzo et al., 2012); [11] (Martin et al., 2009); [12] (Krusche et al., 2011; Kant et al., 2012; Buck et al., 2018); [13]
(Lombardi et al., 2011); [14] (Li et al., 2011); [15] (Li et al., 2011); [16] (Cerrone et al., 2012; Leo-Macias et al., 2015); [17] (Gomes et al., 2012); [18] (Swope et al.,
2012); [19] (Moriarty et al., 2012); [20] (Lyon et al., 2014); [21] (Rimpler, 2014); [22] (Asimaki et al., 2014); [23] (Cruz et al., 2015); [24] (Mezzano et al., 2016); [25]
(Herbert Pratt et al., 2015); [26] (Kant et al., 2015); [27] (Zhang et al., 2015); [28] (Moncayo-Arlandi et al., 2016); [29] (Chelko et al., 2016); [30] (Cerrone et al., 2017);
[31] (Brodehl et al., 2017); [32] (Calore et al., 2019); [33] (Giuliodori et al., 2018); [34] (Hamada et al., 2020).
(Gerull et al., 2019). Homozygous and heterozygous truncating
mutations spread over the total DSP length are common. In
contrast to plakoglobin, the cardiac-specific overexpression of the
wild-type desmoplakin is not toxic (Yang et al., 2006; Figure 3).
However, transgenic mice with cardiac-specific overexpression
of mutant desmoplakin (Myh6:DSP-p.R2834H-FLAG) developed
cardiac fibrosis and apoptosis, leading to ventricular dilation
in combination with cardiac dysfunction and ultrastructural
changes of the intercalated disc (Yang et al., 2006). On the other
hand, an LOF pathomechanism for DSP mutations is supported
by generation and characterization of cardiac-specific Dsp
deficient mice, which causes the homozygous status embryonic
lethality (Garcia-Gras et al., 2006). Heterozygous, cardiac-
specific Dsp knockout mice developed fibro-fatty replacement
of the myocardium and increased cardiomyocyte death, leading
to cardiac dysfunction and ventricular arrhythmia supporting
haploinsufficiency as the underlying pathomechanism (Garcia-
Gras et al., 2006). Interestingly, genes encoding inhibitors of
the WNT pathway and inflammatory proteins were differently
expressed in these mice (Cheedipudi et al., 2019). Knockdown of
dspa and dspb in zebrafish using morpholino injections showed,
in good agreement, altered WNT, TGFβ, and Hippo/YAP-TAZ
signaling (Giuliodori et al., 2018). Downregulation of connexins,
which are the protein building blocks of the gap junctions,
was described in heterozygous and homozygous cardiac specific
Dsp-deficient mice (Gomes et al., 2012; Lyon et al., 2014).
In 2015, Mezzano et al. generated a mouse model with a
cardiac conduction system–specific Dsp ablation, revealing the
impact of desmoplakin for the cardiac pacemaker function
(Mezzano et al., 2016). As human DSP mutations also cause
Carvajal syndrome in addition to isolated ACM, a spontaneous
homozygous Dsprul mouse model deserves attention. Dsprul
mice carry a spontaneous 10-bp insertion, leading to a frame
shift and, consequently, to a premature termination codon in
the C-terminal part of desmoplakin. These mice developed
abnormal coat and epidermal blistering and presented, in
addition, electrophysiological alterations and cardiac fibrosis
(Herbert Pratt et al., 2015). In summary, the majority of animal
models demonstrate an LOF mechanism for DSP, which is,
moreover, supported in humans by the relatively high amount
(5%–10%) of pathogenic truncating DSP mutations associated
with an ACM phenotype.
Plakophilin-2
Mutations in PKP2 are common in ACM, and more than
250 different pathogenic mutations spread over the whole
sequence are listed currently in the HGMD. The majority
of PKP2 mutations are truncating mutations although also
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pathogenic missense mutations are known (Kirchner et al., 2012).
Presumably, haploinsufficiency is the major pathomechanism
caused by PKP2 mutations (Kirchner et al., 2012; Rasmussen
et al., 2014). However, even a homozygous deletion of PKP2
was described in two siblings of a consanguineous family.
Both siblings presented severe left-ventricular noncompaction
cardiomyopathy (LVNC) instead of ACM (Ramond et al., 2017).
Several different animal models support the concept of PKP2
haploinsufficiency (Figure 3). Knockdown of pkp2 in zebrafish
caused cardiac edema, incomplete heart looping, and a decreased
heart rate. The structure of the cardiac desmosomes was,
moreover, altered in these zebrafish (Moriarty et al., 2012).
Because homozygous global Pkp2 deficiency is embryonically
lethal in mice (Grossmann et al., 2004), heterozygous Pkp2-
deficient mice were used for functional analyses (Cerrone
et al., 2012; Leo-Macias et al., 2015). Although no histological
phenotype was present in the heterozygous animals, they
developed electrophysiological abnormalities and ultrastructural
defects (Cerrone et al., 2012; Leo-Macias et al., 2015). However,
two overexpression models of truncated plakophilin-2 might
indicate a toxic effect in mice (Cruz et al., 2015; Moncayo-
Arlandi et al., 2016). Cruz et al. used adeno-associated viruses
(AAVs) to express mutant truncated plakophilin-2 (p.R375X).
In combination with exercise, this overexpression led to right-
ventricular dysfunction. Those findings are similar to a transgenic
mouse model with a cardiac-specific overexpression of Pkp2-
p.S329X. Although, no fibro-fatty replacement was present in
these transgenic mice, electrophysiological abnormalities and
ultrastructural defects were present. In addition, a decreased
expression of the other desmosomal proteins and remodeling of
connexin-43 was found (Moncayo-Arlandi et al., 2016). Recently,
Cerrone et al. developed a cardiac-specific inducible Pkp2 mice
line presenting decreased ventricular function, severe cardiac
fibrosis, and arrhythmia. Interestingly, remodeling of genes
involved in Ca2+ handling was found using this mouse model
(Cerrone et al., 2017). Overall, it may be summarized that there
is high evidence that Pkp2 haploinsufficiency is involved in the
ACM-associated pathomechanism.
Desmoglein-2 and Desmocollin-2
Heterozygous and homozygous pathogenic mutations in DSG2
and DSC2, encoding the two cardiac desmosomal cadherins,
have been identified in human ACM patients responsible for
about 5% of cases (Gerull et al., 2019; Brodehl et al., 2020).
Using morpholino oligonucleotide injections, Heuser et al.
knocked down dsc2l in zebrafish larvae causing cardiac edema,
decreased fractional shortening, and altered desmosomal
structure (Heuser et al., 2006). In contrast, homozygous
conditional Dsc2-deficient mice were, under normal housing
conditions, vital and did not develop cardiac dysfunction or
show an increased mortality (Rimpler, 2014). Interestingly,
homozygous knock-in mice carrying Dsc2-p.G790del did not
develop a cardiac phenotype (Hamada et al., 2020). However,
cardiac-specific overexpression of wild-type desmocollin-2
causes severe biventricular cardiomyopathy, including severe
fibrotic scar formation, cardiac necrosis, calcification, and aseptic
inflammation (Brodehl et al., 2017). Nevertheless, this mouse
model cannot be directly transferred to the human condition
of DSC2 mutation carriers. Therefore, it is currently unknown
if LOF or a pathogenic dosage effect of mutant desmocollin-2
contributes to ACM development.
The situation for desmoglein-2 is even more complex. Two
transgenic mouse models with a cardiac-specific overexpression
of Dsg2-p.N271S and DSG2-p.Q554X have been generated.
The control mice with a cardiac-specific overexpression of the
wild-type DSG2 did not show any structural or functional
abnormalities (Pilichou et al., 2009; Calore et al., 2019).
In contrast, transgenic Myh6:Dsg2-p.N271S mice developed
arrhythmia and ultrastructural defects of the intercalated disc
(Pilichou et al., 2006). Correspondingly, Myh6:DSG2-p.Q554X
mice developed cardiac fibrosis and had a reduced number of
cardiac desmosomes. Interestingly, these mice had an increased
expression of miRNAs signatures, which might be involved in
the pathogenesis (Calore et al., 2019). The group of Krusche
and Leube developed a mutant Dsg2 mouse line missing parts
of the first extracellular domains 1–2, mediating the homophilic
and heterophilic intercellular protein–protein interactions. These
mice developed cardiac fibrosis, necrosis, and calcification and
showed an increased expression of cardiac stress markers.
Ventricular arrhythmia and ultrastructural defects of the cardiac
desmosomes were present in these mice (Krusche et al., 2011;
Kant et al., 2012; Buck et al., 2018). Cardiac-specific Dsg2
knockout mice were independently developed by two groups
(Kant et al., 2015; Chelko et al., 2016). These mice present
typical ACM features, leading to decreased cardiac function and
arrhythmia. Of note, Chelko et al. demonstrated using Dsg2-
deficient mice for which pharmacological inhibition of glycogen
synthase kinase 3β (GSK3β) is able to improve cardiac function,
indicating a putative therapeutic strategy for ACM as previously
found in a transgenic zebrafish model (Asimaki et al., 2014;
Chelko et al., 2016). However, whether inhibition of GSK3β
serves as a therapeutic strategy in humans needs to be tested in
future clinical trials. In addition, the molecular mechanism of
GSK3ß inhibition in the context of ACM is currently unknown.
iASPP
Recently, Notari et al. demonstrated that the inhibitor of
apoptosis-stimulating protein of p53 (iASPP) is a cardiac
desmosomal protein by binding to desmoplakin and desmin
(Notari et al., 2015). However, iASPP is also known as NFκB-
interacting protein-1 (NKIP1) and has a widespread expression
in different organs and cell types3. Of note, a different group
identified a homozygous nonsense mutation in PPP1R13L,
which encodes iASPP, in a consanguineous family by whole
exome sequencing. The infant patients showed severe DCM,
cardiac fibro-fatty replacement, tachycardia, wooly hair,
and wedge-shaped teeth but no palmoplantar keratoderma
(Falik-Zaccai et al., 2017). A spontaneous deletion affecting
a splice site in Ppp1r13l in a mouse model caused abnormal
coat, growth retardation, increased prenatal mortality, and
biventricular cardiomyopathy with massive cardiac fibrosis
(Herron et al., 2005). More recently, an inducible Ppp1r13l
3https://www.proteinatlas.org/ENSG00000104881-PPP1R13L/tissue
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knockout mouse model was generated, which presented an
ACM phenotype consisting of right ventricular dilation,
ventricular tachycardia, and ultrastructural changes of the
cardiac desmosomes (Notari et al., 2015). In addition, a
homozygous 7-bp duplication in PPP1R13L leading to a frame
shift and a premature stop codon is responsible in Poll Hereford
cattle for correspondent cardiac and coat abnormalities, leading
to prenatal death (Simpson et al., 2009).
ANIMAL MODELS FOR ACM
ASSOCIATED WITH MUTATIONS IN
NONDESMOSOMAL GENES
In addition to mutations in desmosomal genes, several rare
mutations in nondesmosomal genes have been identified in
human ACM patients. Those ACM-associated genes encode
proteins involved in cardiac electrophysiology (encoded by
RYR2, SCN5A, PLN), Z-band proteins (encoded by DES, LDB3,
ACTN2), nuclear envelope proteins (encoded by TMEM43,
LMNA, LEMD2), or proteins involved in cell–cell or cell to
extracellular matrix (ECM) adhesion (encoded by CTNNA3,
CDH2, TJP1, ILK, FLNC) (Figures 1, 4 and Supplementary
Tables 1, 2).
Animal Models for ACM Genes Involved
in Cardiac Electrophysiology
The human ACM phenotype is associated with severe ventricular
arrhythmia, often leading to sudden cardiac death at first
presentation. Therefore, mutations in proteins regulating ion
channels and calcium signaling have been proposed as part
of overlapping phenotypes of ACM with primary arrhythmia
syndromes and DCM. The three main representative genes are
RYR2, SCN5A, and PLN.
Ryanodine Receptor 2
The cardiac ryanodine receptor 2 gene (RYR2) has been proposed
as the first nonsyndromic autosomal dominant inherited disease
gene for ACM (MIM #600996; Tiso et al., 2001). Although
the separate entity ACM has been subsequently questioned
as mutations in RYR2 typically lead to exercise or emotion-
induced ventricular tachycardia without overt cardiomyopathy,
referred to as catecholaminergic ventricular tachycardia (CPVT).
Interestingly, three of the four originally described human
mutations have been modeled in mice. The Ryr2-p.R176Q+/−
knock-in mouse (Kannankeril et al., 2006) mimics the human
p.R176Q mutation and shows decreased right ventricular end-
diastolic volumes without histological changes and ventricular
tachycardia after beta-adrenergic stimulation. Two other human
mutations related to ACM have been analyzed in mice
(Shan et al., 2012). However, both Ryr2-p.L433P+/− and
Ryr2-p.N2386I+/− knock-in mice demonstrated induced atrial
fibrillation and leaky calcium channels in the sarcoplasmic
reticulum of atrial myocytes but no structural or functional
changes of cardiomyopathy. In contrast to mouse models of Ryr2
representing gain-of-function mutations, the LOF of Ryr2 in the
global knockout mouse appears to be embryonically lethal at
E10 with developmental defects, such as abnormalities in the
heart tube morphology, large vacuolate sarcoplasmic reticulum,
and structurally abnormal mitochondria (Takeshima et al., 1998).
Moreover, an induced acute loss of half of the Ryr2 protein in the
adult mouse hearts (Bround et al., 2012) leads to severe cardiac
dysfunction, decreased heart rate, and ventricular arrhythmia,
indicating that LOF not only causes fatal arrhythmia, but also has
a role in heart rate control and cardiac remodeling contributing
to heart failure.
Sodium Voltage-Gated Channel α Subunit 5
Mutations in SCN5A encoding the voltage-gated sodium
channel subunit alpha Nav1.5 can cause cardiomyopathies and
channelopathies. Functionally, there is a link to the desmosome
as loss of PKP2 expression alters the amplitude and kinetics
of the sodium current (Sato et al., 2011; Cerrone et al.,
2012). The first description of an ACM-like phenotype with an
SCN5A variant came from a clinical study in which a coved-
type ST-segment was provoked in ACM patients by a sodium
channel blocker (Peters, 2008). Subsequently, a larger study
found in almost 2% of ACM patients rare SCN5A variants
and could show for SCN5A-p.R1898H reduced peak sodium
current and abundance of NaV1.5 in clusters at the intercalated
disc (Te Riele et al., 2017). Classically, gain-of-function SCN5A
mutations cause Long QT syndrome, whereas LOF mutations
are responsible for Brugada syndrome. However, both types of
mutations may cause structural changes, usually in the form of
DCM (Wilde and Amin, 2018). So far, the question remains
whether the cardiomyopathy is a direct consequence of the
mutation because Nav1.5 interacts with the proteins of the
cytoskeleton and intercalated discs or may be secondary due
to conduction defects caused by LOF effects. For example,
mice with reduced 90% Scn5a expression develop conduction
defects and severe biventricular cardiomyopathy (Hesse et al.,
2007), also seen in a mouse and zebrafish model mimicking
the human p.D1275N mutation. Mice homozygous (DN/DN)
for the humanized mutation show conduction slowing and
progressive cardiac dysfunction but no fibrosis (Watanabe et al.,
2011). The transgenic zebrafish expressing the same human
p.D1275N mutation exhibit bradycardia, conduction-system
abnormalities, and premature death but no impaired cardiac
function (Huttner et al., 2013).
Reduced Scn5a of about 50% as seen in heterozygous
knockout hearts showed also impaired atrioventricular
conduction and delayed intraventricular conduction, increased
ventricular refractoriness, and ventricular tachycardia with
characteristics of reentrant excitation. Homozygous mice
were embryonically lethal with severe defects in ventricular
morphology (Papadatos et al., 2002). Likewise, knockdown
of cardiac sodium channels in zebrafish compromised both
early chamber formation and normal patterned growth of
the ventricle, suggesting that cardiac sodium channels in
zebrafish affect heart development via a nonelectrophysiological
mechanism (Chopra et al., 2010).
Another mouse model that modeled the human p.F1759A
mutation showed that incomplete NaV1.5 channel inactivation
is able to drive structural alterations, including atrial and
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(Watanabe et al., 2011); [23] (Koshimizu et al., 2011); [24] (Guo et al., 2012); [25] (Li et al., 2012); [26] (Shan et al., 2012); [27] (Bround et al., 2012); [28] (Haghighi
et al., 2012) [29] (Huttner et al., 2013); [30] (Clemen et al., 2015; Stockigt et al., 2020); [31] (Tapia et al., 2015); [32] (Glynn et al., 2015); [33] (Zou et al., 2015); [34]
(Wan et al., 2016); [35] (Khan et al., 2016; van den Hoogenhof et al., 2018); [36] (Shih et al., 2016); [37] (Begay et al., 2018); [38] (Murayama et al., 2018); [39]
(Stroud et al., 2018); [40] (Huttner et al., 2018); [41] (Padron-Barthe et al., 2019); [42] (Zheng et al., 2019); [43] (Brodehl et al., 2019d); [44] (Santos-Pereira et al.,
2019); [45] (Ding et al., 2019); [46] (Zhou et al., 2020).
ventricular enlargement, myofibrillar disarray, fibrosis and
mitochondrial injury, and electrophysiological dysfunctions
(Wan et al., 2016). Moreover, a mouse model is focusing on
the phosphorylation residue S571 in two Scn5a knock-in mouse
models (p.S571E and p.S571A). Interestingly, the authors could
demonstrate a binary molecular switch for CaMKII-dependent
activation of INa,L without affecting channel properties related to
cardiac function (Glynn et al., 2015).
So far, none of the genetic variants found in typical ACM
patients (Te Riele et al., 2017) have been analyzed in an animal
model to specifically look at changes of the right ventricle;
however, it is likely that LOF mutations are associated with
cardiac dysfunction of the left or both ventricles even if
whether a gain-of-function mechanism due to an interaction with
desmosomal proteins exists remains unclear.
Phospholamban
Disturbed calcium homeostasis has been implicated as a
mechanism for arrhythmogenesis as well as disturbed cardiac
contractility. Phosholamban (encoded by PLN) regulates calcium
handling by reversibly inhibiting the activity of the sarcoplasmic
reticulum calcium ATPase 2 (SERCA2). This is based on the
phosphorylation status through beta-adrenergic activation of
protein kinase A (PKA). Although many human mutations
have been described to cause DCM, an in-frame 3-bp deletion
mutation leading to removal of R14 in phospholamban has been
reported to cause both DCM and ACM, indicating the clinical
overlap of both cardiomyopathies in particular for this mutation
(van der Zwaag et al., 2012; Fish et al., 2016). PLN-p.R14del
appears to be associated with high penetrance and severe disease.
Two mouse models have been generated to mimic human disease.
The transgenic mouse overexpressing the human PLN-p.R14del
in the heart revealed ventricular dilation, myocyte disarray, and
myocardial fibrosis. Mechanistically, it has been proposed that
the dominant effect of the mutation leads to a nonreversible
chronic suppression of SERCA activity based on its lack of PKA-
mediated phosphorylation (Haghighi et al., 2006). Interestingly,
when the wild-type phospholamban got removed by mating
the transgenic mice with the Pln knockout mice, hearts are
hypercontractile and show a progression to cardiac hypertrophy
(Chu et al., 1998; Haghighi et al., 2012). More importantly,
mutant phospholamban did not colocalize with SERCA2a and is
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localized instead at the plasma membrane and alters function of
the Na/K ATPase (NKA). Taken together, the p.R14del mutation
has a complex effect on SR calcium homeostasis, impacting both
PLN inhibition of SERCA and PKA-mediated phosphorylation of
PLN via the beta-adrenergic pathway. In addition, a link between
PLN mutations, disturbed calcium handling, and the intercalated
discs has been postulated. The PLN-p.R14del mutation results
in an accumulation of diastolic calcium, which, in turn,
would be able directly or via an activation of Ca2+ sensitive
proteins, such as calmodulin-dependent kinase II (CaMKII) and
calcineurin (CnA), to affect the maladaptive remodeling of the
macromolecular protein complex that forms the intercalated
disc (van Opbergen et al., 2017). PLN-p.R14del may be a
good example for a phenotype of arrhythmogenic dilated
cardiomyopathy covering both entities of DCM and ACM.
Animal Models for ACM Genes Encoding
Proteins of the Nuclear Envelope
Proteins of the nuclear envelope, which surround the nucleus
and are continuous with the sarcoplasmic reticulum in the cell,
are usually highly conserved and ubiquitously expressed. They
have many distinct functions and are involved in the pathology
of the heart and other organs. They contribute to the assembly
of orderly structures and stability and strength of cells and
participate in the regulation of DNA replication and transcription
through chromatin structures (Stroud, 2018). Human mutations
in TMEM43, LMNA, and LEMD2 have been associated with often
highly penetrant, aggressive disease with respect to ventricular
arrhythmia and sudden cardiac death. In addition, the human
phenotype mainly affects the left or both ventricles, whereas a
predominant right ventricular involvement appears unusual.
Transmembrane Protein-43
The transmembrane protein-43 (TMEM43) localizes in the
inner nuclear membrane, where it interacts with lamin
and other proteins of the linker of nucleoskeleton and
cytoskeleton (LINC) complex (Bengtsson and Otto, 2008). The
best characterized human TMEM43 missense mutation causing
autosomal-dominant inherited ACM (#MIM 604400) is p.S358L.
TMEM43-p.S358L generates a severe sex-influenced lethal
ACM with left ventricular dilation, fibro-fatty replacement of
cardiomyocytes, heart failure, and early death, especially in male
patients (Merner et al., 2008; Hodgkinson et al., 2013; Milting
et al., 2015). Currently, the exact molecular mechanism for earlier
presentation and decreased life expectancy in males is unknown
because TMEM43 is not localized on a gonosome. Information
about the role of TMEM43 in health and disease in vivo have been
assessed just very recently in different mouse models. The first
two mouse models have globally knocked out murine Tmem43
as well as introduced the corresponding human mutation
p.S358L via CRISPR/Cas9 knock-in into Tmem43 (Stroud
et al., 2018). Surprisingly, both mouse models did not show a
cardiac phenotype at baseline and after pressure overload. In
contrast, a very similar Tmem43 knock-in mouse model carrying
the p.S358L mutation, generated by traditional homologous
recombination-mediated genomic targeting, shows features
of cardiomyopathy with fibro-fatty infiltration but preserved
cardiac function. The authors show activation of NFκB/TGFβ
signaling, which may cause the fibrotic changes (Zheng et al.,
2019). More importantly, cardiac-specific overexpression of
human TMEM43-p.S358L in a transgenic model recapitulates
the severe human phenotype. Transgenic hearts show severe
biventricular cardiac dysfunction, fibro-fatty replacement of
the myocardium, and decreased survival. Conduction defects
precede the structural abnormalities. TMEM43-p.S358L showed
partial delocalization to the cytoplasm and reduced interaction
with emerin and β-actin, suggesting that a reduced interaction
between the nucleus and the cytoskeleton contributes to
cardiomyocyte death under biomechanical stress. Inhibition of
the GSK3β pathway improved cardiac function (Padron-Barthe
et al., 2019). However, a lot of questions still remain open,
for example, with regards to the sex-specific effect and the
mechanism of arrhythmia preceding the structural changes.
Lamin A/C
LMNA encodes nuclear proteins lamin A and C, which are
widely expressed IF proteins within the inner nuclear membrane
and a relatively common cause of familial DCM (Stroud, 2018).
Cardiac manifestations are also part of isolated cardiomyopathy
or associated with other syndromic features, ranging from
skeletal myopathies, lipodystrophy, and neuropathy to premature
aging. Patients with LMNA mutations affecting the heart
present with conduction disease and ventricular arrhythmia,
often preceding left and sometimes biventricular dysfunction.
However, screening of typical ACM patients identified LMNA
mutation carriers with severe right ventricular involvement,
sudden cardiac death, and conduction abnormalities, suggesting
a genetic overlap of DCM and ACM (Quarta et al., 2012; Valtuille
et al., 2013). Mouse models carrying several missense mutations
have been generated (Chen et al., 2019); however, a particular
mutation with an overlapping phenotype to ACM has not been
reported. More generally, homozygous Lmna knockout mice
showed severely retarded postnatal growth with the appearance
of muscular dystrophy and DCM and died by about 8 weeks
of age mimicking a phenotype of Emery–Dreifuss muscular
dystrophy, DCM, and progeria (Sullivan et al., 1999; Nikolova
et al., 2004). However, human DCM is an autosomal-dominant
disease and, therefore, heterozygous mice for Lmna+/- have
been further evaluated and which demonstrate atrioventricular
(AV) conduction defects, atrial and ventricular arrhythmia, and
at an advanced age also impaired cardiac contractility, which
mimics haploinsufficiency of human disease (Wolf et al., 2008).
Knockdown of lamin during zebrafish development shows also a
cardiomyopathic phenotype with significant bradycardia (Vogel
et al., 2009), whereas another zebrafish model in which cryptic
splicing of lmna generated a deletion of eight amino acids
revealed embryonic senescence and S-phase accumulation/arrest
as well as abnormal muscle and lipodystrophic phenotypes
(Koshimizu et al., 2011). Finally, the underlying pathogenesis
for LMNA mutations causing cardiac features is complex and
part of a multisystem disease pathology. The type of LMNA
mutation may modify the risk of disease progression and
arrhythmia; however, many human missense mutations appear
to be extensively heterogeneous, but in particular, truncating
Frontiers in Physiology | www.frontiersin.org 9 June 2020 | Volume 11 | Article 624
fphys-11-00624 June 22, 2020 Time: 18:18 # 10
Gerull and Brodehl Animal Models of ACM
mutations seem to have a higher risk for arrhythmia and sudden
cardiac death (van Rijsingen et al., 2012).
LEM-Domain Containing Protein-2
More recently a human homozygous missense mutation (p.L13R)
in another inner nuclear membrane protein, encoding the LEM-
domain containing protein-2 (LEMD2), has been found to cause
an ACM with juvenile cataract in the Hutterite population. The
cardiac phenotype is characterized by ventricular arrhythmia and
sudden cardiac death, which often precedes dilation and left-
ventricular dysfunction (Abdelfatah et al., 2019). Interestingly,
mutations in the same gene but a different domain cause a
progeria-like phenotype (Marbach et al., 2019). So far, there is
no mouse model simulating this specific mutation, but the global
knockout of Lemd2 in mice is embryonically lethal at E11.5 and
shows reduced size of most tissues with thin myocardium and
underdeveloped trabeculae, suggesting an importance of Lemd2
during mouse development (Tapia et al., 2015). More specific data
about the role of LEMD2 in the development of cardiomyopathy
are required to explain the clinical phenotype and its pathology,
which appears not to be neither classical for DCM nor ACM and
may present an overlap of both forms.
Animal Models for ACM Genes Encoding
Z-Band Proteins
Z-bands are multiple-protein structures responsible for
anchoring thin sarcomeric filaments as well as the giant
sarcomere protein titin (Luther, 2009) and impact the structural
integrity of the sarcomeres. Mutations in several genes involved
in Z-band formation are involved in genetic cardiomyopathies,
including ACM (Gerull et al., 2019).
Desmin
Although desmin is not directly a Z-band protein, it forms
cytoplasmic IF and is involved in connection of the Z-bands
(Hijikata et al., 1999), desmosomes (Choi et al., 2002),
mitochondria (Capetanaki, 2002), and also the nuclei (Heffler
et al., 2020) in cardiomyocytes. Mutations in DES cause different
skeletal and cardiac myopathies, including DCM (Li et al., 1999;
Brodehl et al., 2016a), HCM (Harada et al., 2018), RCM (Brodehl
et al., 2019c), LVNC (Marakhonov et al., 2019; Kubanek et al.,
2020), and also ACM (Klauke et al., 2010; Bermudez-Jimenez
et al., 2018). Desmin consists of a central α-helical rod domain
flanked by nonhelical head and tail domains. The majority of
pathogenic DES mutations are heterozygous missense or small
in-frame deletion mutations spread over the whole rod domain
(Brodehl et al., 2018). Many DES mutations disturb dominantly
the filament assembly and cause an abnormal cytoplasmic desmin
aggregation (Brodehl et al., 2012). In the 1990s, two groups
independently generated Des-deficient mice models (Li et al.,
1996; Capetanaki et al., 1997). Des-deficient mice develop severe
fibrosis, cardiac calcification, and biventricular cardiomyopathy
(Psarras et al., 2012). Correspondingly, knockdown of desma
and desmb causes cardiac edema and structural disorganized
muscles in zebrafish (Li et al., 2013). However, the major
pathomechanism consisting of abnormal desmin aggregation
is not modeled by this LOF animal model. In contrast, the
Des-p.R349P knock-in mice developed toxic desmin aggregates
and presented mitochondrial defects (Clemen et al., 2015;
Winter et al., 2016; Stockigt et al., 2020). These mice developed
skeletal myopathy in combination with DCM, including cardiac
arrhythmia and conduction defects. In 2015, Ramspacher et al.
inserted fluorescence proteins at position 460 in desma of the
zebrafish (Ramspacher et al., 2015). These zebrafish developed
cardiac arrhythmia and cardiac dysfunction, leading to decreased
viability. In conclusion, desmin animal models suited for
modeling of LOF and toxic dominant desmin accumulation are
available and partially mimic human ACM.
LIM Domain Binding Protein-3
Mutations in LDB3, encoding LIM domain binding protein-
3, which is also known as cipher or ZASP, cause myofibrillar
myopathy and different cardiomyopathies in humans (Vatta
et al., 2003; Selcen and Engel, 2005). ZASP binds to α-
actinin-2 and is important for the structural integrity of the
Z-bands (Lin et al., 2014). In 2015, Lopez-Ayala and coworkers
identified the novel heterozygous missense mutation LDB3-
c.1051A > G in the genome of an ACM index patient using a
next-generation sequencing (NGS) gene panel. Cascade genetic
screening revealed cosegregation of this mutation within the
family supporting its pathogenicity (Lopez-Ayala et al., 2015).
In 2009, Zheng et al. developed conditional cardiac-specific and
inducible cardiac-specific Ldb3 deficient mouse models (Zheng
et al., 2009). Both mouse models presented severe biventricular
dilation and cardiac dysfunction, leading to increased mortality.
Of note, the Z-bands were highly disorganized in cardiomyocytes
from Ldb3-deficient mice, and the ERK/Stat3 signaling was
altered (Zheng et al., 2009). In addition, a transgenic mouse
model with cardiac-specific overexpression of mutant LDB3-
p.S196L was generated (Li et al., 2010). These mice developed
DCM in combination with cardiac conduction defects and
ventricular arrhythmia associated with ultrastructural defects
of the sarcomeres.
α-Actinin-2
Recently, a novel missense mutation p.Y473C was identified in
ACTN2, encoding α-actinin-2, in a family with left-dominant
ACM (Good et al., 2020). Pathogenic mutations in ACTN2
have been also identified in patients with HCM, DCM, and
LVNC, indicating a genetic overlap of associated phenotypes
(Mohapatra et al., 2003; Bagnall et al., 2014; Girolami et al., 2014).
α-Actinin-2 anchors actin filaments and titin to the Z-bands.
Gupta et al. knocked down actn2 in zebrafish using morpholino
oligonucleotide injections, revealing skeletal and cardiac muscle
defects (Gupta et al., 2012). However, there is currently no
specific mouse or zebrafish model available for ACM-associated
human ACTN2 mutations.
Animal Models for ACM Genes Encoding
Proteins Involved in Cell–Cell and
Cell-ECM Adhesion
Mutations in five genes (CTNNA3, CDH2, TJP1, ILK, FLNC)
encoding proteins involved in cell–cell or ECM interaction are
associated with human ACM (Figure 1). However, because these
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mutations have been discovered recently, the amount and impact
for ACM is currently inexplicit. Nevertheless, for some of them,
specific animal models provide additional evidence for their
pathogenicity (Figure 4).
αT-Catenin
Rampazzo’s group identified a CTNNA3 missense and a small
in-frame 3-bp deletion in two ACM families (van Hengel et al.,
2013). However, it seems that CTNNA3 mutations are rare
(Christensen et al., 2011; Gandjbakhch et al., 2013). CTNNA3
encodes αT-Catenin, which is a structural protein involved in the
area composita. Of note, conditional Cttna3 knockout mice were
viable and fertile but developed progressive cardiomyopathy,
including left-ventricular dilation and decreased ejection fraction
(Li et al., 2012). Despite that, the relevance of CTNNA3 for ACM
or other cardiomyopathies has to be investigated in more detail.
N-Cadherin
Recently, two independent groups identified CDH2 missense
variants (p.D407N and p.Q229P) in the genome of ACM
patients (Mayosi et al., 2017; Turkowski et al., 2017; Figure 1).
Cosegregation analyses within the families and absence in
population databases might indicate pathogenicity of these
CDH2 mutations. Similar to the desmosomal cadherins,
N-cadherin is localized in multiple-protein complexes in
the intercalated disc, which are called adherens junctions or
area composita (Franke et al., 2006; Zhao et al., 2019). The
relevance of N-cadherin for ACM is additionally supported
by two different mouse models (Figure 4). Cardiac-specific
overexpression of chicken CDH2 caused biventricular
cardiomyopathy in combination with increased expression
of stress markers and a decreased connexin-43 expression
(Ferreira-Cornwell et al., 2002). Similarly, cardiac-specific
inducible Cdh2 knockout mice developed DCM in combination
with ventricular arrhythmia and conduction abnormalities,
leading to premature death after 2 months (Kostetskii et al.,
2005; Li et al., 2005). Although no functional data about
human CDH2 mutations were currently available, both mouse
models underline the impact of N-cadherin for normal heart
function in vivo. However, future studies are needed to
determine the pathomechanism of CDH2 mutations at the
molecular level.
Tight Junction Protein-1
Currently, there is one single report describing four different
TJP1 missense mutations in ACM patients (De Bortoli et al.,
2018). TJP1 encodes tight junction protein-1 localized at the
intercalated disc, which is also known as zonula occludens-
1 (ZO1). Global knockout of TJP1 caused embryonic lethality
in mice, limiting functional analyses (Katsuno et al., 2008).
Because of the limited knowledge about the relevance of
tight junction protein-1 in ACM, cardiac-specific conditional
knockout or knock-in animal models might contribute to clinical
interpretation of TJP1 mutations in future.
Integrin-Linked Kinase
Recently, we identified two different missense mutations in ILK
in the genome of ACM patients by NGS. One of these mutations
occurred de novo (Brodehl et al., 2019d). Before, ILK mutations
have been described for DCM patients (Knoll et al., 2007). ILK
encodes integrin-linked kinase. There is still an ongoing debate
about whether ILK is a real or pseudo kinase involved in linkage
to the integrin system (Hannigan et al., 2011; Ghatak et al.,
2013; Vaynberg et al., 2018). Transgenic zebrafish with a cardiac-
specific overexpression of mutant ILK presented a decreased
fractional shorting and showed premature death (Brodehl
et al., 2019d). Correspondingly, a spontaneous homozygous ilk
mutation (p.L308P) caused cardiac edema, decreased cardiac
function, and premature death in the zebrafish (Bendig et al.,
2006; Pott et al., 2018). Muscle-specific Ilk knockout mice showed
an increased mortality, ventricular dilation, arrhythmia, and
cardiac fibrosis (White et al., 2006; Quang et al., 2015). In
addition, Akt phosphorylation was reduced, and connexin-43
was downregulated in these mice.
Filamin-C
Mutations in FLNC were initially identified in patients with
myofibrillar myopathy (MFM) (Vorgerd et al., 2005; Shatunov
et al., 2009). FLNC encodes filamin-c, which is a huge cytolinker
protein involved in linkage of the area composita, costameres,
and actin filaments. The relevance of FLNC mutations for
development of different cardiomyopathies, such as HCM
(Valdes-Mas et al., 2014), RCM (Brodehl et al., 2016b), and
DCM (Begay et al., 2016; Nozari et al., 2018) has been more
recently recognized. In addition, mutations in FLNC cause
ACM (Begay et al., 2018; Hall et al., 2019, 2020; Augusto
et al., 2020; Brun et al., 2020). Global or cardiac-specific
Flnc deficiency was embryonically lethal in mice, limiting the
functional analyses (Zhou et al., 2020). Mice expressing a
mutant C-terminal truncated form of filamin-C died perinatal
by respiratory failure, but no detailed cardiac analyses have
been performed (Dalkilic et al., 2006). Therefore, Chen’s
group developed inducible cardiac-specific Flnc-deficient mice.
These mice showed premature death, increased cardiac stress
marker expression, cardiac fibrosis, and cardiac dysfunction.
Interestingly, several proteins of the costameres, the intercalated
discs, or the IFs were highly increased (Zhou et al., 2020). In
summary, there is evidence from human and animal data that
demonstrate the impact of filamin-C for heart function. However,
the specific impact of FLNC mutations for ACM needs further
investigation in the future.
Animal Models for ACM Genes Involved
RNA Binding and Processing
Mutations in RBM20, encoding the RNA-binding motif protein
20 (RBM20), have been recently identified in patients with ACM
(van den Hoogenhof et al., 2018; Parikh et al., 2019). Initially,
pathogenic missense mutations in RBM20 were described in
DCM (Brauch et al., 2009) and LVNC patients (Sedaghat-
Hamedani et al., 2017). RBM20 is a splicing factor and consists
of one N-terminal leucine-rich domain, two zinc finger domains,
a RNA recognition motif, an arginine- and serine-rich (RS)
domain and a glutamate-rich region (Watanabe et al., 2018).
The majority of pathogenic RBM20 mutations is localized in
the RS domain although also mutations in the glutamate-rich
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region have been described (Beqqali et al., 2016). Using a
spontaneous rat model carrying a homozygous large deletion
affecting rbm20, Guo et al. revealed that Rbm20 is involved
in cardiac splicing of several genes, including ttn (titin) and
ldb3. Of note, several of the known targets of Rbm20, such
as RYR2, are ACM-associated genes. Maatz et al. determined
further RBM20 target genes, such as Myh7, Nexn, Tnnt2, and
Ryr2 (Maatz et al., 2014). The Rbm20-deficient mice presented
cardiomyopathy in combination with arrhythmia, leading to
increased mortality. This phenotype in rats is in good agreement
with the phenotype of cardiac-specific Rbm20-deficient mice,
which developed arrhythmogenic DCM (Khan et al., 2016; van
den Hoogenhof et al., 2018). Interestingly, adenovirus-mediated
Rbm20 overexpression rescued the ttn splicing defect in rbm20-
deficient cardiomyocytes, underlining a putative therapeutic
strategy (Guo et al., 2012). Murayama and colleagues generated
a knock-in mouse model carrying Rbm20-p.S647A in the RS
domain. Although the detailed phenotype of these mice has
yet not been described in detail, the authors demonstrated
defects in splicing of titin in the murine heart (Murayama
et al., 2018). Interestingly, mutations in the RS domain prevent
nuclear transport of RBM20 (Murayama et al., 2018; Brodehl
et al., 2019b). Another ACM-associated gene encoding a putative
RNA-binding protein (Han et al., 2019) might be SORBS2,
encoding sorbin and SH3 domain-containing protein-2 (Ding
et al., 2019). The exact molecular function of SORBS2 is
currently unknown. However, in a preprinted manuscript, Ding
et al. described several novel human SORBS2 variants in ACM
patients and generated cardiac-specific Sorbs2-deficient mice.
These mice develop biventricular cardiomyopathy, leading to an
increased mortality (Ding et al., 2019). However, it is currently
unclear if SORBS2 is a RNA-binding protein or a desmosomal
protein. Currently, it is difficult to predict the relevance of
SORBS2 in ACM.
Further Animal Models for Human
ACM-Associated Genes
Few additional genes have been reported in association with
ACM either as part of an overlap phenotype with other
cardiomyopathies (TTN) or where the genes have been suggested
as a candidate gene for ACM (TGFβ3) or as part of a complex
syndrome (TP63). Their overall importance for the disease
remains elusive.
Titin
Truncating mutations (TTNtv) in the sarcomeric gene TTN have
been reported with a frequency of approximately 25% as the
most common cause of DCM (Herman et al., 2012; Roberts
et al., 2015). However, their role for other cardiomyopathies
remains elusive (Gerull, 2015). Moreover, missense variants,
which are predicted to be deleterious, are found in about 7% of
DCM patients, which was comparable with the frequency in the
reference population, suggesting that their causative relevance for
DCM is not established (Akinrinade et al., 2019). For ACM, two
studies have been published in which exclusively TTN missense
variants have been suggested as a cause of ACM (Taylor et al.,
2011; Brun et al., 2014), which might be, under current view,
questionable although a modifying effect cannot be excluded.
Interestingly, in particular, the zebrafish has been used to
mimic different TTNtv, but also a mouse model has been
developed, which corresponds to a human A-band truncation
mutation (Gerull et al., 2002). Mice homozygous for the
truncation are embryonically lethal at E9.5 due to defects in
the sarcomere formation, whereas heterozygous animals have no
cardiac abnormalities at baseline but develop fibrotic remodeling
under hemodynamic stress (Gramlich et al., 2009). Using
different genome-editing approaches, truncation mutations have
been introduced and analyzed at different locations of the
zebrafish ttn gene (Zou et al., 2015; Shih et al., 2016; Huttner
et al., 2018). Homozygous truncations at the N-terminal
and C-terminal molecule caused severe defects in cardiac
contractility, and the zebrafish died within 2 weeks. Interestingly,
C-terminal truncations led to severe skeletal muscle myopathies
but not N-terminal. A newly discovered internal promotor
produces the so-called C-terminal titin isoform “Cronos,” which
is translated into a protein and explains the differences between
the phenotypes, depending on the location of the truncation
with or without a subsequent disruption of the “Cronos” isoform
(Zou et al., 2015). Others also modeled truncation mutations
in zebrafish and supported the exon usage hypothesis (Shih
et al., 2016), which was previously suggested based on human
studies (Roberts et al., 2015). The impact of heterozygous ttn
truncations at an adult age was further investigated. Like in
humans, heterozygous truncations led to spontaneous DCM with
reduced baseline ventricular systolic function and failed to mount
a hypercontractile response when challenged by hemodynamic
stress (Huttner et al., 2018).
Transforming Growth Factor-ß3
The first genomic locus for ACM at 14q23-q24 (ARVD1; #MIM
107970) was discovered by linkage analysis in Italian families, but
a pathogenic mutation in exonic sequences of several candidate
genes was not detected (Rampazzo et al., 2003). Later on, two
genetic variants in the untranslated regions of the transforming
growth factor-β3 (TGFβ3) were identified; however, the role of
TGFβ3 as a causative gene for ACM (Beffagna et al., 2005)
remains still open. Moreover, Tgf β3 knockout mice showed
no specific cardiac phenotype but suffer from abnormal lung
development and cleft palate at birth (Kaartinen et al., 1995;
Proetzel et al., 1995). On the other hand, TGFβ signaling has
been suggested to play a role in the disease process of ACM and
has been shown to be activated in the pathogenesis of TMEM43-
related disease as well as for mutant desmosomal proteins, such
as plakoglobin and desmoplakin (Li et al., 2011; Giuliodori et al.,
2018; Zheng et al., 2019).
Tumor Protein-63
Another interesting protein is the tumor protein p63 (TP63).
Mutations in TP63 can cause a range of overlapping syndromic
ectodermal dysplasias (EDs). In some cases of EDs, a congenital
heart defect was found; however, a case report described
a missense mutation in TP63 in a patient with ED and
typical cardiac findings of ACM (Valenzise et al., 2008).
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More recently, a novel heterozygous nonsense variant was
reported in a typical nonsyndromic ACM case, suggesting that
haploinsufficiency may play a role in the disease process (Poloni
et al., 2019). Knockout of Tp63 in mice and zebrafish are
viable and indicate its role in development and ectodermal
differentiation, but no obvious cardiac abnormalities have
been detected in either homozygous or heterozygous animals
(Mills et al., 1999; Santos-Pereira et al., 2019). A potential
role for TP63 as an ACM associated gene needs to be
further defined.
ACM ANIMAL MODELS WITHOUT
HUMAN GENETIC CORRELATION
Several animal models have been described for which the
responsible gene is still unknown or no human genetic
mutations have been associated with ACM. Asano et al.
generated a spontaneous mouse model with massive right-
ventricular fibrosis, calcification, and prolonged QRS duration
with recessive inheritance. Linkage analyses revealed a 1031-
bp retroposon in the Rpsa gene. Rpsa or Lamr1 encodes the
laminin receptor-1, which is also called ribosomal protein SA.
Transgenic mice with cardiac-specific or systemic overexpression
of this mutant form of the laminin receptor 1 caused ACM,
supporting the pathogenicity of this mutant gene (Asano
et al., 2004). In humans, heterozygous mutations in RPSA
cause isolated congenital asplenia by haploinsufficiency (MIM,
#271400) (Bolze et al., 2013).
Since the 1980s, it has been recognized that ACM occurred
in Boxer dogs with similar clinical signs to humans, including
ventricular arrhythmia, ventricular dilation, and fibro-fatty
replacement of the myocardium (Miller et al., 1985; Harpster,
1991; Basso et al., 2004). Nearly all mouse and zebrafish models
are unable to display fibro-fatty replacement of myocardial
tissue, which is a typical hallmark of human ACM. In
contrast, the Boxer ACM model is also able to mimic those
pathological findings. In addition, inflammatory cell infiltration
and apoptosis were present in this large-animal model (Basso
et al., 2004). Meurs et al. analyzed pedigrees of Boxer dogs
and suggested an autosomal dominant inheritance (Meurs
et al., 1999). Based on a genome-wide association study,
a deletion in the untranslated region of STRN, encoding
striatin, was suggested as the pathogenic mutation causing
Boxer ACM (Meurs et al., 2010). However, Cattanach et al.
demonstrated that this STRN mutation is not causative for
Boxer ACM, but might be genetically linked to the responsible
gene on chromosome 17 (Cattanach et al., 2015). Currently,
no STRN mutation for human ACM patients is listed in
the HGMD or the ARVD/C Genetic Database4. In addition,
ACM was described for English Bulldogs and Weimaraners
(Eason et al., 2015; Cunningham et al., 2018). Corresponding
to Boxer ACM, it was shown that ACM presented with
right-ventricular dilation, thin right-ventricular wall diameter,
ventricular tachycardia, and severe fibro-fatty replacement of the
4https://molgenis136.gcc.rug.nl
myocardium, which occurred spontaneously in domestic cats
(Fox et al., 2000; Harvey et al., 2005; Ciaramella et al., 2009).
However, the genetic mutations responsible for ACM in cats is
currently unknown.
SUMMARY AND OUTLOOK
Because the first disease genes of ACM were discovered more
than 20 years ago, a substantial number of in vivo models
have been generated and characterized to fill the important gap
between the underlying genetic defect and the observed clinical
phenotype. Those models often recapitulate at least partially
pathological features of ACM and gain mechanistic insights into
the disease pathogenesis with the opportunity to develop targeted
therapies in the future. However, a past in vivo model strategy
mimics LOF much better due to targeted knockouts of affected
proteins, but it is limited in modeling missense mutations, often
leading to a gain-of-function or toxic effect. Transgenic models
used for missense mutations still mainly overexpress the human
mutant proteins, which often have different effects in mice
compared to the human phenotype. Knock-in animal models
represent a much better system for studying human missense
mutations as the mutation is inserted into the endogenous gene
and works under the control of its own promotor. Nevertheless,
even if the human disease mutation is conserved, it is still kept in
mind that substantial differences exist between the human heart
and mice or fish hearts. In particular in ACM, the hallmark of
fatty tissue in the human right ventricle is almost never seen in the
corresponding model system. From recent advances in genetic
technology emerged the CRISPR/Cas9 genome-editing approach,
which has simplified the generation of knockout and knock-in
models and will become the technology of choice for studying
human gene mutations in the future.
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